Pancreas Pathology During the Natural History of Type 1 Diabetes

Teresa Rodriguez-Calvo, Sarah J. Richardson, Alberto Pugliese

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purpose of review: We provide an overview of pancreas pathology in type 1 diabetes (T1D) in the context of its clinical stages. Recent findings: Recent studies of pancreata from organ donors with T1D and non-diabetic donors expressing T1D-associated autoantibodies reveal pathological changes/disease mechanisms beyond the well-known loss of β cells and lymphocytic infiltrates of the islets (insulitis), including β-cell stress, dysfunction, and viral infections. Pancreas pathology evolves through disease stages, is asynchronous, and demonstrates a chronic disease that remains active years after diagnosis. Critically, β-cell loss is not complete at onset, although young age is associated with increased severity. Summary: The recognition of multiple pathogenic alterations and the chronic nature of disease mechanisms during and after the development of T1D inform improved clinical trial design and reveal additional targets for therapeutic manipulation, in the context of an expanded time window for intervention.

Original languageEnglish (US)
Article number124
JournalCurrent Diabetes Reports
Volume18
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Type 1 Diabetes Mellitus
Pancreas
Pathology
Chronic Disease
Tissue Donors
Virus Diseases
Autoantibodies
Clinical Trials
Therapeutics

Keywords

  • Insulitis
  • Islet autoimmunity
  • Pancreas
  • Type 1 diabetes
  • β cell

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Pancreas Pathology During the Natural History of Type 1 Diabetes. / Rodriguez-Calvo, Teresa; Richardson, Sarah J.; Pugliese, Alberto.

In: Current Diabetes Reports, Vol. 18, No. 11, 124, 01.11.2018.

Research output: Contribution to journalReview article

Rodriguez-Calvo, Teresa ; Richardson, Sarah J. ; Pugliese, Alberto. / Pancreas Pathology During the Natural History of Type 1 Diabetes. In: Current Diabetes Reports. 2018 ; Vol. 18, No. 11.
@article{4867aa33c6104bda8e56e5eca4588667,
title = "Pancreas Pathology During the Natural History of Type 1 Diabetes",
abstract = "Purpose of review: We provide an overview of pancreas pathology in type 1 diabetes (T1D) in the context of its clinical stages. Recent findings: Recent studies of pancreata from organ donors with T1D and non-diabetic donors expressing T1D-associated autoantibodies reveal pathological changes/disease mechanisms beyond the well-known loss of β cells and lymphocytic infiltrates of the islets (insulitis), including β-cell stress, dysfunction, and viral infections. Pancreas pathology evolves through disease stages, is asynchronous, and demonstrates a chronic disease that remains active years after diagnosis. Critically, β-cell loss is not complete at onset, although young age is associated with increased severity. Summary: The recognition of multiple pathogenic alterations and the chronic nature of disease mechanisms during and after the development of T1D inform improved clinical trial design and reveal additional targets for therapeutic manipulation, in the context of an expanded time window for intervention.",
keywords = "Insulitis, Islet autoimmunity, Pancreas, Type 1 diabetes, β cell",
author = "Teresa Rodriguez-Calvo and Richardson, {Sarah J.} and Alberto Pugliese",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s11892-018-1084-3",
language = "English (US)",
volume = "18",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - Pancreas Pathology During the Natural History of Type 1 Diabetes

AU - Rodriguez-Calvo, Teresa

AU - Richardson, Sarah J.

AU - Pugliese, Alberto

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose of review: We provide an overview of pancreas pathology in type 1 diabetes (T1D) in the context of its clinical stages. Recent findings: Recent studies of pancreata from organ donors with T1D and non-diabetic donors expressing T1D-associated autoantibodies reveal pathological changes/disease mechanisms beyond the well-known loss of β cells and lymphocytic infiltrates of the islets (insulitis), including β-cell stress, dysfunction, and viral infections. Pancreas pathology evolves through disease stages, is asynchronous, and demonstrates a chronic disease that remains active years after diagnosis. Critically, β-cell loss is not complete at onset, although young age is associated with increased severity. Summary: The recognition of multiple pathogenic alterations and the chronic nature of disease mechanisms during and after the development of T1D inform improved clinical trial design and reveal additional targets for therapeutic manipulation, in the context of an expanded time window for intervention.

AB - Purpose of review: We provide an overview of pancreas pathology in type 1 diabetes (T1D) in the context of its clinical stages. Recent findings: Recent studies of pancreata from organ donors with T1D and non-diabetic donors expressing T1D-associated autoantibodies reveal pathological changes/disease mechanisms beyond the well-known loss of β cells and lymphocytic infiltrates of the islets (insulitis), including β-cell stress, dysfunction, and viral infections. Pancreas pathology evolves through disease stages, is asynchronous, and demonstrates a chronic disease that remains active years after diagnosis. Critically, β-cell loss is not complete at onset, although young age is associated with increased severity. Summary: The recognition of multiple pathogenic alterations and the chronic nature of disease mechanisms during and after the development of T1D inform improved clinical trial design and reveal additional targets for therapeutic manipulation, in the context of an expanded time window for intervention.

KW - Insulitis

KW - Islet autoimmunity

KW - Pancreas

KW - Type 1 diabetes

KW - β cell

UR - http://www.scopus.com/inward/record.url?scp=85054462565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054462565&partnerID=8YFLogxK

U2 - 10.1007/s11892-018-1084-3

DO - 10.1007/s11892-018-1084-3

M3 - Review article

VL - 18

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 11

M1 - 124

ER -